Page last updated: 2024-09-02

sch 28080 and acridine orange

sch 28080 has been researched along with acridine orange in 1 studies

Compound Research Comparison

Studies (sch 28080)	Trials (sch 28080)	Recent Studies (post-2010) (sch 28080)	Studies (acridine orange)	Trials (acridine orange)	Recent Studies (post-2010) (acridine orange)
217	0	20	2,310	19	343

Protein Interaction Comparison

Protein	Taxonomy	sch 28080 (IC50)	acridine orange (IC50)
Amyloid-beta precursor protein	Homo sapiens (human)		0.6

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ife, RJ; Keeling, DJ; Laing, SM; Leach, CA; Malcolm, RC	1

Other Studies

1 other study(ies) available for sch 28080 and acridine orange

Article	Year
SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase. Biochemical pharmacology, 1991, Jun-21, Volume: 42, Issue:1 Topics: Acridine Orange; Adenosine Triphosphatases; Aminoquinolines; Animals; Binding Sites; Binding, Competitive; Dose-Response Relationship, Drug; Gastric Fundus; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Imidazoles; Kinetics; Potassium; Swine	1991

Article

Year

SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase.

Biochemical pharmacology, 1991, Jun-21, Volume: 42, Issue:1

Topics: Acridine Orange; Adenosine Triphosphatases; Aminoquinolines; Animals; Binding Sites; Binding, Competitive; Dose-Response Relationship, Drug; Gastric Fundus; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Imidazoles; Kinetics; Potassium; Swine

1991